Loading candles…
J.B. Chemicals and Pharmaceuticals Limited, incorporated in 1976, operates as an integrated pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and contract development and manufacturing organization (CDMO) services. The company serves both the domestic Indian market and international markets. It holds a publicly-listed status and maintains a strong presence in India with several flagship brands. J.B. Chemicals is recognized for providing affordable pharmaceutical products and is trusted by healthcare professionals globally. The company operates within the pharmaceutical industry but does not have any publicly noted subsidiaries or ventures.
| Dividend |
| This is to intimate you that meeting of the Board of Directors of the Company will be held on February 5, 2026, inter alia, to consider declaration of Interi… |
| 5 Feb 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the unaudited financial results for the quarter and nine months ending December 31, 2025 | 16 Jan 2026 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended Jun 30, 2025 | 30 Jul 2025 |
| Results - Q4 & FY25 | To consider and approve the financial results for the quarter and year ended on March 31, 2025 and to consider and recommend dividend on equity shares of the… | 14 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.